Skip to main content

22-953: Submit Attestations Online for Chronically Ill Members

December 1, 2022

Effective January 1, 2023, fax attestations are no longer accepted

Special Supplemental Benefits for Chronically Ill (SSBCI) are offered to Wellcare’s highest-risk members who meet specific criteria for eligibility based on the Centers for Medicare and Medicaid Services (CMS) guidelines.

Effective January 1, 2023, you can check eligibility requirements and submit attestations on behalf of members online at ssbci.rrd.com.

Steps to determine eligibility, submit attestations and activate benefits

Members are required to schedule an office visit with their doctor or participating physician group for evaluation. Once appointment is made follow the steps below:

  1. Visit ssbci.rrd.com.
  2. Follow the steps on ssbci.rrd.com. to evaluate your patient against the eligibility requirements outlined on ssbci.rrd.com.
  3. Submit an attestation form through ssbci.rrd.com indicating your patient meets the eligibility requirements.
  4. Submit a claim with the appropriate diagnosis codes from this office visit indicating a member has been diagnosed with one or more qualifying chronic conditions listed on ssbci.rrd.com.
  5. Upon receipt of all required information, the member will be sent an approval or denial letter within 10 business days. Approval letters include information on steps the member should follow to activate supplemental member benefits.

If you have questions regarding the information contained in this update, contact 866-999-3945.


This update applies to Medicare Providers: Physicians, Independent Practice Associations, Hospitals, & Ancillary Providers.

Contact Us icon

Need help? We're here for you.

Contact Us
Last Updated On: 8/12/2024
Wellcare will be performing maintenance on Saturday, December 21, from 6 P.M. EDT to 8 A.M. EDT the next day. You might not be able to access systems or fax during this time. We are sorry for any issues this may cause. Thank you for your patience. If you need assistance, contact us. ×